BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 16, 2009
View Archived Issues
Ziopharm's Bet: Cancer Pills Will Beat I.V.; Off-On Method Intrigues
"Ruthlessly efficient" is how Jonathan Lewis, CEO and chief medical officer of Ziopharm Oncology Inc., last week described his firm's approach to research and financial management.
Read More
Money Raised Year to Date
Read More
No Public Funds or Partners: Can Istodax Be New Approval Model?
Read More
Enzon's Specialty-Biz Offload Leaves Convertible Overhang
Read More
Money Raised By Biotech in 2009
Read More
Week in Review
Read More
Word on the Street
Read More
Week in Washington
Read More
FDA Approvals for October
Read More
Phase I Clinical Trials Update: October 2009
Read More
Phase II Clinical Trials Update: October 2009
Read More
Pivotal/Phase III Clinical Trials Update: October 2009
Read More
American College of Rheumatology
Read More
American Association for the Study of Liver Disease
Read More
Non-U.S. Clinical Trials And Regulatory Actions: October 2009
Read More
FDA Submissions, Approvals And Other Actions: October 2009
Read More
Stock Gainers and Losers For The Week
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More